Dr. Ivan M. Borrello is a hematologist oncologist and renowned physician-scientist who serves as Medical Director of the Myeloma, Bone Marrow Transplant (BMT) and Cell Therapies program within the TGH Cancer Institute. Fluent in English, Italian, Spanish and Portuguese, Dr. Borrello is recognized as a leader in the field of immunotherapy of hematologic malignancies (leukemias, lymphomas, multiple myeloma) as well as bone marrow and stem cell transplants.
Dr. Borrello joined TGH Cancer Institute from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, where he was Director of Cellular Therapeutics, a member of the Cancer Immunology and Immunotherapy Program, and an Associate Professor of Oncology. He built a premier Multiple Myeloma Program and served as its director before joining Tampa General. Dr. Borrello received his medical degree from the Medical College of Virginia, completed his internal medicine residency at the University of Chicago and fellowship in medical oncology at the Johns Hopkins Oncology Center at Johns Hopkins University.
Dr. Borrello’s clinical research interest is in developing immune-based therapies for the treatment of multiple myeloma — cancer of the plasma cells. His published works include his participation in more than 100 peer-reviewed original research articles and he’s credited with numerous inventions, patents and copyrights in areas of his medical expertise. Dr. Borrello has memberships with the American Association of Cancer Research, the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology, and the Society for Biological Therapy.
Tampa General Hospital Cancer Institute
Address: 3 Tampa General Circle
Phone: (813) 844-7585
Fax: (813) 844-5877
Medical School Medical College of Virginia (Richmond, Va.)
Residency Internal Medicine University of Chicago (Chicago, Ill.)
Fellowship Medical Oncology Johns Hopkins Oncology Center, Johns Hopkins University (Baltimore, Md.)